Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Staphefekt versus placebo for skin and nasal Staphylococcus aureus in adults with atopic dermatitis
NL-OMON40588Not yet recruiting
- Sponsor
- Micreos
- Start
- Apr 2016
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of Staphefekt in atopic dermatitis (AD) (2 arms), sponsored by Micreos. Primary endpoints: Dynamics of Staphylococcus aureus after Staphefekt application and Effect on atopic dermatitis severity. Planned start Apr 2016; status: not yet recruiting.
02
Drugs
Staphefekt
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NL-OMON40588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40588.